Get started
Author

Esther J. Schrama

Observed names: E Schrama, E. Schrama, Esther J. Schrama, Esther Schrama, Schrama, Esther J.
ORCID: 0000-0003-3716-6584
Observed ORCID: 0000-0003-3716-6584
OpenAlex ID: A5113940653
Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane
1994 · J. T. Tamsma, J. van den Born, et al. · Diabetologia · 178
PDF
IL-1α stimulated TNFα production by cultured human proximal tubular epithelial cells
1992 · Benito A. Yard, Mohamed R. Daha, et al. · Kidney International · 97
Interleukin 6 production by human proximal tubular epithelial cells in vitro: analysis of the effects of interleukin-1α (IL-1α) and other cytokines
1994 · R. N. Boswell, B. A. Yard, et al. · Nephrology Dialysis Transplantation · 76
Interstitial Rejection, Vascular Rejection, and Diffuse Thrombosis of Renal Allografts
1996 · M. F. Kooijmans-Coutinho, J. Hermans, et al. · Transplantation · 54
T-cell receptors and IC AM-1 expression in renal allografts during rejection
1991 · W. Moolenaar, J. A. Bruijn, et al. · Transplant International · 42
Evaluation by histology, immunohistology and PCR of protocollized renal biopsies 1 week post-transplant in relation to subsequent rejection episodes
1995 · M. F. Kooijmans-Coutinho, J. A. Bruijn, et al. · Nephrology Dialysis Transplantation · 17
Value of Anti-neutrophil Cytoplasmic Autoantibodies and Other Laboratory Parameters in Follow-up of Vasculitis
1990 · C. Halma, M. R. Daha, et al. · Scandinavian Journal of Rheumatology · 14
The role of unconventional alloantigens in interstitial and vascular rejection after renal transplantation
1994 · Fokko J. van der Woude, E. Schrama, et al. · Transplant Immunology · 13
Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane RID=""ID="" Abbreviations: HS: Heparan sulphate; GBM: glomerular basement membrane; HSPG: heparan sulphate proteoglycan; NC: noncollagenous globular domain; IDDM, insulin-dependent diabetes mellitus; NIDDM, non-insulin-dependent diabetes mellitus
1994 · J. Hermans, J. H. Veerkamp, et al. · Diabetologia · 11
PDF
Tissue antigens in tubulointerstitial and vascular rejection.
1995 · F J van der Woude, J G Deckers, et al. · PubMed · 10
Isolation from purulent sputum of an antigen reactive with antibodies in serum of patients with Wegener's granulomatosis.
1990 · M R Daha, J Leusen, et al. · PubMed · 8
Contrasting Becker and Duchenne muscular dystrophy serum biomarker candidates by using data independent acquisition LC-MS/MS
2025 · Camilla Johansson, Esther J. Schrama, et al. · Skeletal Muscle · 7
PDF
IgA class anti-neutrophil cytoplasmic antibodies (IgA-ANCA) in primary IgA nephropathy.
1989 · A W van den Wall Bake, M R Daha, et al. · PubMed · 7
Skeletal Muscle Membrane Permeability Markers Derived From 31P‐MRS May Reflect Disease Activity in Becker Muscular Dystrophy
2025 · Esther J. Schrama, Melissa T. Hooijmans, et al. · NMR in Biomedicine · 4
P301 Novel JAG2 variants in the first identified Dutch patient with limb-girdle muscular dystrophy R27 and a neuropsychiatric phenotype
2023 · E. Schrama, E. Niks, et al. · Neuromuscular Disorders · 3
Sensitivity of Different Clinical Outcome Measures in Assessing Adults With Becker Muscular Dystrophy
2025 · Esther J. Schrama, Zaïda Koeks, et al. · Neurology · 2
Identification of Gene‐Therapy Responsive Blood Biomarkers in mdx Mouse Model
2024 · Camilla Johansson, Jessica F. Boehler, et al. · JCSM Communications · 1
PDF
Response to Letter to the Editor: ‘Muscle Membrane Permeability Determined by 31 P‐MRS and DT‐MRI as a Biomarker for the Progression of Becker Muscular Dystrophy’
2026 · Esther J. Schrama, Melissa T. Hooijmans, et al. · NMR in Biomedicine
PDF
629PTrajectory of north star ambulatory assessment with sevasemten compares favorably to natural history modeling in Becker muscular dystrophy
2025 · E. Niks, J. Signorovitch, et al. · Neuromuscular Disorders
647PSerum levels of ART3 and RGMa are associated with functional performance in Becker muscular dystrophy
2025 · P. Spitali, E. Schrama, et al. · Neuromuscular Disorders
539PThe latest insights from the Dutch LGMD registry through patient- and clinician- reported data
2025 · R. Hoek, E. Schrama, et al. · Neuromuscular Disorders
605P Dutch LGMD registry: real-world data to facilitate trial readiness
2024 · E. Schrama, R. Hoek, et al. · Neuromuscular Disorders
648P MRI demonstrates altered skeletal muscle membrane permeability in Becker muscular dystrophy, representing a potential biomarker for disease activity
2024 · E. Schrama, M. Hooijmans, et al. · Neuromuscular Disorders
Towards patient-friendly arterial-spin-labeling MRI in muscle: Effect of exercise intensity and standardisation on perfusion parameters
2024 · Donnie Cameron, Esther Schrama, et al. · Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
Signal-to-noise requirements for accurate and precise perfusion parameter estimation with pulsed arterial spin labeling MRI in skeletal muscle
2023 · Donnie Cameron, Thom Veeger, et al. · Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
Works count: 40
Citation count: 544
H-index: 10
I10-index: 10
Year
Topic
Type